CTX and Idiopathic Bilateral Cataracts in Pediatric Patients

CTX and Idiopathic Bilateral Cataracts in Pediatric Patients

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is no longer recruiting.

Description
CTX is typically a highly progressive disease, with case reports of symptoms that first appear at any time from birth through adulthood and then worsen over time. Because idiopathic bilateral cataracts occur at an early age in many children with CTX, biomarker testing of these children presents an opportunity for diagnosing children with CTX. Eligible participants will be asked to give a small blood sample and urine sample, and may have genetic testing done to see if they have the gene for CTX. This study will take place on 1 visit for approximately 30 minutes.

Eligibility and criteria
IRB Number:
16-012960
Eligible age range:
2 years - 21 years
Clinical trial phase:
N/A
Official title:
An Observational, Multicenter Study of the Prevalence of Cerebrotendinous Xanthomatosis (CTX) inPatient Populations Diagnosed with Early-Onset Idiopathic Bilateral Cataracts

Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.